Previous 10 | Next 10 |
Ten years doesn't sound like a long time. In the world of investing, it can seem like eons. Some reports show investors hold the average stock just 5-1/2 months. For a trader focusing on the stock price, that's a lot of red or green days that aren't very meaningful to the business. For an i...
The following slide deck was published by Pacific Biosciences of California, Inc. in conjunction with this event. For further details see: Pacific Biosciences of California (PACB) Presents At BofA Securities 2021 Virtual Health Care Conference - Slideshow
InvestorPlace - Stock Market News, Stock Advice & Trading Tips It’s been quite the year for the life sciences company, Bionano Genomics (NASDAQ: BNGO ). BNGO stock was trading for as little as 50 cents late last year before the short squeeze lifted the stock past it past t...
PacBio saw strong system placements in the first quarter, including multiple multi-system orders, multiple new customers, and orders for COVID-19 surveillance. The key for PacBio remains driving down the cost of the technology; long-read sequencing can already do many things that shor...
Cathie Wood has gained notoriety from making some seemingly outlandish calls on stocks and for being right. Her company's extrapolation of real world data and technological trends has proved to be an incredibly profitable investing strategy, even after some recent turbulence. One of her...
Pacira BioSciences (PACB) has announced $43.1M and $1.5M preliminary net product sales for EXPAREL (bupivacaine liposome injectable suspension) and iovera, respectively. During the month, EXPAREL average daily sales reached 449% of April 2020, the company said.“The Pacira Inn...
I operate two main portfolios: my "safe" portfolio and my high growth portfolio. This article will dissect and focus on my high-growth holdings. I generally like to invest in themes and tend to take a shotgun approach to my holdings in emerging sectors. I will list my holdings for 8 s...
ARKG’s Sharpe Ratio and outperformance suggest great stock-picking by the fund manager. However, the neutral rating is premised on a long-term time horizon for value realization in view of ARKG’s rich valuation. Furthermore, the general market is not unequivocally ri...
Genome sequencing specialist Pacific Biosciences of California (NASDAQ: PACB) reported first-quarter 2021 financial results on Thursday afternoon that were right in line with analyst estimates. But in yet another example of a company falling sharply following a decent earnings repor...
Gainers: Brooklyn ImmunoTherapeutics (BTX) +38%, Motus GI MOTS +32%, CryoLife (CRY) +16%, Mesoblast MESO +14%, Arcutis Biotherapeutics (ARQT) +10%.Losers: Ardelyx (ARDX) -13%, Pacific Biosciences of California (PACB) -13%, ALX Oncolo...
News, Short Squeeze, Breakout and More Instantly...
Pacific Biosciences of California Inc. Company Name:
PACB Stock Symbol:
NASDAQ Market:
Pacific Biosciences of California Inc. Website:
2024-07-26 10:45:04 ET Pacific Biosciences of California Inc (PACB) PACB is trading UP for the last 5 days, and it at trading at $2.10 with volume of 3,952,245 and a one day change of $0.19 (9.97%). Pacific Biosciences of California Inc has a 52-week low of 1.16 and a 52-week high o...
MENLO PARK, Calif., July 23, 2024 (GLOBE NEWSWIRE) -- PacBio (NASDAQ: PACB), a leading developer of high-quality, highly accurate sequencing solutions, today announced that Novogene is using its Revio long-read sequencing system to expand the capabilities of its new lab in Munich, Germany, se...
A look at the top 10 most actives in the United States Yoshitsu Co. Ltd (TKLF) rose 103.4% to $0.623 on volume of 309,019,720 shares Maxeon Solar Technologies Ltd. (MAXN) rose 11.2% to $0.2524 on volume of 226,231,487 shares NVIDIA Corporation (NVDA) fell 1.6% to $126.36 on volume of 208,...